Melissa J Clay, NP
Nurse Practitioner · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Bradley B Hill MD A Professional Corporation · 4 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Melissa J Clay’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$45,101
Medicare paid this office $45,101 for 274 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 100 | $8,459 | $68 |
| Return visit (30+ min) | 65 | $7,406 | $101 |
| Long return visit (40+ min) | 37 | $6,308 | $147 |
| New patient visit (45+ min) | 28 | $3,548 | $127 |
| New patient visit (60+ min) | 19 | $3,139 | $165 |
See all 9 services
| Short return visit (20+ min) | 100 | $8,459 | $68 |
| Return visit (30+ min) | 65 | $7,406 | $101 |
| Long return visit (40+ min) | 37 | $6,308 | $147 |
| New patient visit (45+ min) | 28 | $3,548 | $127 |
| New patient visit (60+ min) | 19 | $3,139 | $165 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $2,613 | $105 |
| Telephone medical discussion with physician, 11-20 minutes | 35 | $2,595 | $72 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 90 | $1,396 | $13 |
| Short return visit | 20 | $997 | $47 |
Procedures Medicare counted
| Laminectomy or laminotomy (partial removal of spine bones) | 11 | More than 35% of doctors who do this |
| Spinal fusion | 19 | More than 36% of doctors who do this |
Who their Medicare patients are
274 Original Medicare patients in 2024. Average age 75 · Under 65 13% · 85 and older 17% · Women 51% · Also on Medicaid 30% · Health risk score 3.93. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Chronic kidney disease 53% · Diabetes 47% · Coronary heart disease 43% · Heart failure 36% · Atrial fibrillation 27% · Cancer 21% · Depression 18% · COPD 15% · Stroke 13% · Dementia 10%.
The office billed $235,436, Medicare allowed $58,677 and paid $45,101; for 584 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 274 | 584 | 75 | 3.93 | $235,436 | $45,101 |
| 2023 | 230 | 492 | 77 | 3.75 | $211,650 | $44,881 |
| 2022 | 79 | 130 | 76 | 2.54 | $61,509 | $12,226 |
| 2021 | 27 | 100 | 73 | 0.84 | $82,727 | $8,823 |
| 2020 | 18 | 82 | 72 | 1.18 | $77,005 | $6,366 |
| 2019 | 51 | 201 | 74 | 1.17 | $171,616 | $13,591 |
| 2018 | 49 | 115 | 76 | 1.19 | $85,971 | $8,407 |
| 2017 | 41 | 142 | 75 | 1.20 | $66,656 | $10,148 |
| 2016 | 44 | 155 | 76 | 1.06 | $73,445 | $11,422 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Short return visit (20+ min) | 122 | $13,199 | $71 |
| Return visit (30+ min) | 75 | $9,927 | $101 |
| New patient visit (45+ min) | 51 | $6,354 | $125 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $3,634 | $104 |
| New patient visit (60+ min) | 19 | $3,244 | $171 |
| Telephone medical discussion with physician, 11-20 minutes | 43 | $3,121 | $73 |
| Long return visit (40+ min) | 21 | $2,804 | $134 |
| Short return visit | 16 | $661 | $41 |
2022: 3 services
| New patient visit (45+ min) | 18 | $2,407 | $134 |
| Return visit (30+ min) | 18 | $1,876 | $104 |
| Short return visit (20+ min) | 19 | $1,481 | $74 |
2019: 3 services
| Fusion of spine in lower back | 14 | $2,678 | $191 |
| Insertion of cage or mesh device to spine bone and disc space during spine fusion | 15 | $723 | $26 |
| Short return visit (20+ min) | 12 | $463 | $39 |
2018: 1 service
| Short return visit (20+ min) | 30 | $1,527 | $48 |
2017: 2 services
| Short return visit (20+ min) | 19 | $882 | $46 |
| Insertion of cage or mesh device to spine bone and disc space during spine fusion | 11 | $635 | $30 |
2016: 2 services
| Insertion of spinal instrumentation for spinal stabilization | 12 | $1,143 | $48 |
| Short return visit (20+ min) | 19 | $1,108 | $55 |
Drugs they prescribed that Part D paid
$14,331
Pharmacies billed $14,331 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 24) in 2024. Too few prescriptions to compare fairly with other clinicians.
0 generic and 22 brand-name prescriptions · $14,331 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 17 | $9,318 | $548 |
Year by year
| 2024 | 24 | None | 0% (0) | 92% | $14,331 |
| 2023 | 30 | 11 | 0% (0) | 57% | $13,477 |
| 2022 | 58 | 29 | 29% (17) | 0% | $595 |
| 2021 | 134 | 55 | 30% (40) | None | $2,146 |
| 2020 | 111 | 45 | 32% (36) | 0% | $2,243 |
| 2019 | 103 | 42 | 52% (53) | None | $4,724 |
| 2018 | 87 | 29 | 25% (22) | None | $4,590 |
| 2017 | 92 | 38 | 27% (25) | None | $3,352 |
| 2016 | 105 | 41 | 39% (41) | None | $1,722 |
| 2015 | 57 | 28 | 61% (35) | None | $839 |
| 2014 | 17 | None | None | None | $2,067 |
| 2013 | 45 | None | 58% (26) | 24% | $5,012 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Eliquis | 12 | $9,969 | $831 |
2022: 1 drug
| Gabapentin | 20 | $194 | $10 |
2021: 4 drugs
| Gabapentin | 34 | $560 | $16 |
| Hydrocodone-Acetaminophen | 17 | $165 | $10 |
| Cyclobenzaprine | 11 | $86 | $8 |
| Meloxicam | 20 | $82 | $4 |
2020: 3 drugs
| Gabapentin | 37 | $630 | $17 |
| Hydrocodone-Acetaminophen | 14 | $148 | $11 |
| Meloxicam | 16 | $51 | $3 |
2019: 4 drugs
| Gabapentin | 18 | $2,627 | $146 |
| Tramadol | 25 | $256 | $10 |
| Hydrocodone-Acetaminophen | 16 | $216 | $14 |
| Cyclobenzaprine | 12 | $53 | $4 |
2018: 2 drugs
| Gabapentin | 34 | $2,286 | $67 |
| Meloxicam | 11 | $18 | $2 |
2017: 1 drug
| Gabapentin | 37 | $843 | $23 |
2016: 4 drugs
| Gabapentin | 34 | $471 | $14 |
| Hydrocodone-Acetaminophen | 12 | $207 | $17 |
| Tramadol | 21 | $192 | $9 |
| Meloxicam | 18 | $85 | $5 |
2015: 1 drug
| Tramadol | 20 | $213 | $11 |
2013: 1 drug
| Oxycodone Hcl-Acetaminophen | 11 | $1,082 | $98 |
Money from drug and device companies
$82 in 2025
| 2025 | 2 | 3 | None | $82 |
| 2024 | 3 | 3 | None | $94 |
| 2023 | 5 | 10 | None | $245 |
| 2022 | 4 | 5 | None | $121 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Varithena Administration Pack | $44 | 1 payment
|
| Becton Dickinson and | Rotarexs 6 F X 135 Cm | $38 | 2 payments
|
See all 3 published payments
| Becton Dickinson and | Meals · 2025-12-10 | None | $20 |
| Boston Scientific | Meals · 2025-10-23 | Varithena Administration Pack | $44 |
| Becton Dickinson and | Meals · 2025-10-22 | Rotarexs 6 F X 135 Cm | $18 |
See earlier years (2024, 2023, 2022)
2024: $94
| Inari Medical | Flowtriever Catheter, S | $38 | 1 payment
|
| Bard Peripheral Vascular | None | $32 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $24 | 1 payment
|
2023: $245
| Janssen Pharmaceuticals | Xarelto | $165 | 6 payments
|
| Biotissue Holdings | Neox | $25 | 1 payment
|
| ConvaTec | Innovamatrix Ac | $21 | 1 payment
|
| Smith+Nephew | Grafix | $19 | 1 payment
|
| Medtronic | Closurerfs | $15 | 1 payment
|
2022: $121
| Janssen Pharmaceuticals | Xarelto | $51 | 2 payments
|
| Smith+Nephew | Grafix Pl | $33 | 1 payment
|
| Abbott Laboratories | Perclose Proglide | $25 | 1 payment
|
| Boston Scientific | General - Pain Management | $12 | 1 payment
|
Professional record
- NPI
- 1881894236
- Licence
- CA NP16766
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 1400 Emeline Ave, Santa Cruz, CA, 95060
- NPI first listed
- 2007-07-24
- NPI last updated
- 2009-05-14
This is when the NPI record was last certified, not a medical board exam.